MicroRNA-31 contributes to colorectal cancer development by targeting factor inhibiting HIF-1α (FIH-1)

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63:11 - 30; http://dx.doi.org/10.3322/caac.21166; PMID: 23335087
   PubMed Web of Science ®Google Scholar
• Sakamoto T, Niiya D, Seiki M. Targeting the Warburg effect that arises in tumor cells expressing membrane type-1 matrix metalloproteinase. J Biol Chem 2011; 286:14691 - 704; http://dx.doi.org/10.1074/jbc.M110.188714; PMID: 21372132
   PubMed Web of Science ®Google Scholar
• Semenza GL. HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev 2010; 20:51 - 6; http://dx.doi.org/10.1016/j.gde.2009.10.009; PMID: 19942427
   PubMed Web of Science ®Google Scholar
• Kuwai T, Kitadai Y, Tanaka S, Onogawa S, Matsutani N, Kaio E, Ito M, Chayama K. Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer 2003; 105:176 - 81; http://dx.doi.org/10.1002/ijc.11068; PMID: 12673675
   PubMed Web of Science ®Google Scholar
• Furlan D, Sahnane N, Carnevali I, Cerutti R, Uccella S, Bertolini V, Chiaravalli AM, Capella C. Up-regulation and stabilization of HIF-1alpha in colorectal carcinomas. Surg Oncol 2007; 16:Suppl 1 S25 - 7; http://dx.doi.org/10.1016/j.suronc.2007.10.014; PMID: 18023174
   PubMedGoogle Scholar
• Harris AL. Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2:38 - 47; http://dx.doi.org/10.1038/nrc704; PMID: 11902584
   PubMed Web of Science ®Google Scholar
• Mahon PC, Hirota K, Semenza GL. FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 2001; 15:2675 - 86; http://dx.doi.org/10.1101/gad.924501; PMID: 11641274
   PubMed Web of Science ®Google Scholar
• Cockman ME, Lancaster DE, Stolze IP, Hewitson KS, McDonough MA, Coleman ML, Coles CH, Yu X, Hay RT, Ley SC, et al. Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH). Proc Natl Acad Sci U S A 2006; 103:14767 - 72; http://dx.doi.org/10.1073/pnas.0606877103; PMID: 17003112
   PubMed Web of Science ®Google Scholar
• Coleman ML, McDonough MA, Hewitson KS, Coles C, Mecinovic J, Edelmann M, Cook KM, Cockman ME, Lancaster DE, Kessler BM, et al. Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor. J Biol Chem 2007; 282:24027 - 38; http://dx.doi.org/10.1074/jbc.M704102200; PMID: 17573339
   PubMed Web of Science ®Google Scholar
• Couvelard A, Deschamps L, Rebours V, Sauvanet A, Gatter K, Pezzella F, Ruszniewski P, Bedossa P. Overexpression of the oxygen sensors PHD-1, PHD-2, PHD-3, and FIH Is associated with tumor aggressiveness in pancreatic endocrine tumors. Clin Cancer Res 2008; 14:6634 - 9; http://dx.doi.org/10.1158/1078-0432.CCR-07-5258; PMID: 18927305
   PubMed Web of Science ®Google Scholar
• Giatromanolaki A, Koukourakis MI, Pezzella F, Turley H, Sivridis E, Bouros D, Bougioukas G, Harris AL, Gatter KC. Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway. Cancer Lett 2008; 262:87 - 93; http://dx.doi.org/10.1016/j.canlet.2007.11.041; PMID: 18187257
   PubMed Web of Science ®Google Scholar
• Liu CJ, Tsai MM, Hung PS, Kao SY, Liu TY, Wu KJ, Chiou SH, Lin SC, Chang KW. miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Res 2010; 70:1635 - 44; http://dx.doi.org/10.1158/0008-5472.CAN-09-2291; PMID: 20145132
   PubMed Web of Science ®Google Scholar
• Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M, Nenutil R, Vyzula R. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 2007; 72:397 - 402; http://dx.doi.org/10.1159/000113489; PMID: 18196926
   PubMed Web of Science ®Google Scholar
• Wang CJ, Zhou ZG, Wang L, Yang L, Zhou B, Gu J, Chen HY, Sun XF. Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer. Dis Markers 2009; 26:27 - 34; http://dx.doi.org/10.1155/2009/921907; PMID: 19242066
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487:330 - 7; http://dx.doi.org/10.1038/nature11252; PMID: 22810696
   PubMed Web of Science ®Google Scholar
• Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 2000; 157:411 - 21; http://dx.doi.org/10.1016/S0002-9440(10)64554-3; PMID: 10934146
   PubMed Web of Science ®Google Scholar
• Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, Simons JW. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 1999; 59:5830 - 5; PMID: 10582706
   PubMed Web of Science ®Google Scholar
• Crosby ME, Kulshreshtha R, Ivan M, Glazer PM. MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res 2009; 69:1221 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-08-2516; PMID: 19141645
   PubMed Web of Science ®Google Scholar
• Pocock R. Invited review: decoding the microRNA response to hypoxia. Pflugers Arch 2011; 461:307 - 15; http://dx.doi.org/10.1007/s00424-010-0910-5; PMID: 21207057
   PubMed Web of Science ®Google Scholar
• Oberg AL, French AJ, Sarver AL, Subramanian S, Morlan BW, Riska SM, Borralho PM, Cunningham JM, Boardman LA, Wang L, et al. miRNA expression in colon polyps provides evidence for a multihit model of colon cancer. PLoS One 2011; 6:e20465; http://dx.doi.org/10.1371/journal.pone.0020465; PMID: 21694772
   PubMed Web of Science ®Google Scholar
• Cekaite L, Rantala JK, Bruun J, Guriby M, Agesen TH, Danielsen SA, Lind GE, Nesbakken A, Kallioniemi O, Lothe RA, et al. MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer. Neoplasia 2012; 14:868 - 79; PMID: 23019418
   PubMed Web of Science ®Google Scholar
• Cekaite L, Rantala JK, Bruun J, Guriby M, Agesen TH, Danielsen SA, Lind GE, Nesbakken A, Kallioniemi O, Lothe RA, et al. MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer. Neoplasia 2012; 14:868 - 79; PMID: 23019418
   PubMed Web of Science ®Google Scholar
• Peng H, Hamanaka RB, Katsnelson J, Hao LL, Yang W, Chandel NS, Lavker RM. MicroRNA-31 targets FIH-1 to positively regulate corneal epithelial glycogen metabolism. FASEB J 2012; 26:3140 - 7; http://dx.doi.org/10.1096/fj.11-198515; PMID: 22532441
   PubMed Web of Science ®Google Scholar
• Sun D, Yu F, Ma Y, Zhao R, Chen X, Zhu J, Zhang CY, Chen J, Zhang J. MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1). J Biol Chem 2013; 288:9508 - 18; http://dx.doi.org/10.1074/jbc.M112.367763; PMID: 23322774
   PubMed Web of Science ®Google Scholar
• Yu J, Ryan DG, Getsios S, Oliveira-Fernandes M, Fatima A, Lavker RM. MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia. Proc Natl Acad Sci U S A 2008; 105:19300 - 5; http://dx.doi.org/10.1073/pnas.0803992105; PMID: 19033458
   PubMed Web of Science ®Google Scholar